FOLR2 and lung adenocarcinoma: As shown in Fig. 2f, a significant difference existed in the overall survival between patients with high FRβ expression and those with low FRβ expression in interstitial TAMs in lung adenocarcinoma (p = 0.0077, HR = 0.5325, 95% CI 0.3296–0.8604).